 | • レポートコード：D0804-15660 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、102ページ • 納品方法：Eメール • 産業分類：新技術 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、新型コロナウイルス感染症用ワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。新型コロナウイルス感染症用ワクチンの種類別市場規模（コロナウイルス不活化ワクチン、弱毒生ワクチン、Sタンパク質ベースワクチン）、用途別市場規模（病院、クリニック、研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Іnоvіо Рhаrmасеutісаlѕ、GGеnеСurе、Рrоtеіn Роtеntіаl、Моdеrnа、NаnоVіrісіdеѕ、Nоvаvах、Ѕуnаіrgеn РLС、АlрhаVах ・地域別グローバル市場分析 2015年-2020年 ・新型コロナウイルス感染症用ワクチンの北米市場（アメリカ、カナダ、メキシコ） ・新型コロナウイルス感染症用ワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・新型コロナウイルス感染症用ワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・新型コロナウイルス感染症用ワクチンの南米市場（ブラジル、アルゼンチン） ・新型コロナウイルス感染症用ワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：コロナウイルス不活化ワクチン、弱毒生ワクチン、Sタンパク質ベースワクチン ・用途別分析：病院、クリニック、研究所、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Coronavirus Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Coronavirus Vaccine sales will be xx in 2020 from Coronavirus Vaccine million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Coronavirus Vaccine market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Coronavirus Vaccine industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Coronavirus Vaccine and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Coronavirus Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Coronavirus Vaccine market has been segmented into:
Coronavirus Inactivated Vaccine
Live Attenuated Coronavirus Vaccine
Coronavirus Vaccine Based On S Protein
By Application, Coronavirus Vaccine has been segmented into:
Hospital
Clinic
Research Institute
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Coronavirus Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Coronavirus Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Coronavirus Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the Coronavirus Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Coronavirus Vaccine Market Share Analysis
Coronavirus Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Coronavirus Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Coronavirus Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in Coronavirus Vaccine are:
Іnоvіо Рhаrmасеutісаlѕ
GGеnеСurе
Рrоtеіn Роtеntіаl
Моdеrnа
NаnоVіrісіdеѕ
Nоvаvах
Ѕуnаіrgеn РLС
АlрhаVах
Among other players domestic and global, Coronavirus Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Coronavirus Vaccine Market Overview
1.1 Product Overview and Scope of Coronavirus Vaccine
1.2 Classification of Coronavirus Vaccine by Type
1.2.1 Global Coronavirus Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Coronavirus Vaccine Revenue Market Share by Type in 2019
1.2.3 Coronavirus Inactivated Vaccine
1.2.4 Live Attenuated Coronavirus Vaccine
1.2.5 Coronavirus Vaccine Based On S Protein
1.3 Global Coronavirus Vaccine Market by Application
1.3.1 Overview: Global Coronavirus Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.3.5 Other
1.4 Global Coronavirus Vaccine Market by Regions
1.4.1 Global Coronavirus Vaccine Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Coronavirus Vaccine (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Coronavirus Vaccine Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Coronavirus Vaccine Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Coronavirus Vaccine Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Coronavirus Vaccine Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Coronavirus Vaccine Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Coronavirus Vaccine Industry Impact
1.5.1 COVID-19 Potential Implications for the Coronavirus Vaccine
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Coronavirus Vaccine
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Іnоvіо Рhаrmасеutісаlѕ
2.1.1 Іnоvіо Рhаrmасеutісаlѕ Details
2.1.2 Іnоvіо Рhаrmасеutісаlѕ Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Іnоvіо Рhаrmасеutісаlѕ SWOT Analysis
2.1.4 Іnоvіо Рhаrmасеutісаlѕ Product and Services
2.1.5 Іnоvіо Рhаrmасеutісаlѕ Coronavirus Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.2 GGеnеСurе
2.2.1 GGеnеСurе Details
2.2.2 GGеnеСurе Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 GGеnеСurе SWOT Analysis
2.2.4 GGеnеСurе Product and Services
2.2.5 GGеnеСurе Coronavirus Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.3 Рrоtеіn Роtеntіаl
2.3.1 Рrоtеіn Роtеntіаl Details
2.3.2 Рrоtеіn Роtеntіаl Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Рrоtеіn Роtеntіаl SWOT Analysis
2.3.4 Рrоtеіn Роtеntіаl Product and Services
2.3.5 Рrоtеіn Роtеntіаl Coronavirus Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.4 Моdеrnа
2.4.1 Моdеrnа Details
2.4.2 Моdеrnа Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Моdеrnа SWOT Analysis
2.4.4 Моdеrnа Product and Services
2.4.5 Моdеrnа Coronavirus Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.5 NаnоVіrісіdеѕ
2.5.1 NаnоVіrісіdеѕ Details
2.5.2 NаnоVіrісіdеѕ Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 NаnоVіrісіdеѕ SWOT Analysis
2.5.4 NаnоVіrісіdеѕ Product and Services
2.5.5 NаnоVіrісіdеѕ Coronavirus Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.6 Nоvаvах
2.6.1 Nоvаvах Details
2.6.2 Nоvаvах Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Nоvаvах SWOT Analysis
2.6.4 Nоvаvах Product and Services
2.6.5 Nоvаvах Coronavirus Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.7 Ѕуnаіrgеn РLС
2.7.1 Ѕуnаіrgеn РLС Details
2.7.2 Ѕуnаіrgеn РLС Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Ѕуnаіrgеn РLС SWOT Analysis
2.7.4 Ѕуnаіrgеn РLС Product and Services
2.7.5 Ѕуnаіrgеn РLС Coronavirus Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.8 АlрhаVах
2.8.1 АlрhаVах Details
2.8.2 АlрhаVах Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 АlрhаVах SWOT Analysis
2.8.4 АlрhаVах Product and Services
2.8.5 АlрhаVах Coronavirus Vaccine Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Coronavirus Vaccine Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Coronavirus Vaccine Players Market Share
3.2.2 Top 10 Coronavirus Vaccine Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Coronavirus Vaccine Revenue and Market Share by Regions
4.2 North America Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
4.3 Europe Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
4.5 South America Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
5 North America Coronavirus Vaccine Revenue by Countries
5.1 North America Coronavirus Vaccine Revenue by Countries (2015-2020)
5.2 USA Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
5.3 Canada Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
5.4 Mexico Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
6 Europe Coronavirus Vaccine Revenue by Countries
6.1 Europe Coronavirus Vaccine Revenue by Countries (2015-2020)
6.2 Germany Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
6.3 UK Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
6.4 France Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
6.5 Russia Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
6.6 Italy Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Coronavirus Vaccine Revenue by Countries
7.1 Asia-Pacific Coronavirus Vaccine Revenue by Countries (2015-2020)
7.2 China Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
7.3 Japan Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
7.4 Korea Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
7.5 India Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
8 South America Coronavirus Vaccine Revenue by Countries
8.1 South America Coronavirus Vaccine Revenue by Countries (2015-2020)
8.2 Brazil Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
8.3 Argentina Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Coronavirus Vaccine by Countries
9.1 Middle East & Africa Coronavirus Vaccine Revenue by Countries (2015-2020)
9.2 Saudi Arabia Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
9.3 UAE Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
9.4 Egypt Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
9.5 South Africa Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Coronavirus Vaccine Revenue and Market Share by Type (2015-2020)
10.2 Global Coronavirus Vaccine Market Forecast by Type (2019-2024)
10.3 Coronavirus Inactivated Vaccine Revenue Growth Rate (2015-2025)
10.4 Live Attenuated Coronavirus Vaccine Revenue Growth Rate (2015-2025)
10.5 Coronavirus Vaccine Based On S Protein Revenue Growth Rate (2015-2025)
11 Global Coronavirus Vaccine Market Segment by Application
11.1 Global Coronavirus Vaccine Revenue Market Share by Application (2015-2020)
11.2 Coronavirus Vaccine Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Research Institute Revenue Growth (2015-2020)
11.6 Other Revenue Growth (2015-2020)
12 Global Coronavirus Vaccine Market Size Forecast (2021-2025)
12.1 Global Coronavirus Vaccine Market Size Forecast (2021-2025)
12.2 Global Coronavirus Vaccine Market Forecast by Regions (2021-2025)
12.3 North America Coronavirus Vaccine Revenue Market Forecast (2021-2025)
12.4 Europe Coronavirus Vaccine Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Coronavirus Vaccine Revenue Market Forecast (2021-2025)
12.6 South America Coronavirus Vaccine Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Coronavirus Vaccine Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Coronavirus Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Coronavirus Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Coronavirus Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Coronavirus Vaccine Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Coronavirus Vaccine Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Іnоvіо Рhаrmасеutісаlѕ Corporate Information, Location and Competitors
Table 7. Іnоvіо Рhаrmасеutісаlѕ Coronavirus Vaccine Major Business
Table 8. Іnоvіо Рhаrmасеutісаlѕ Coronavirus Vaccine Total Revenue (USD Million) (2017-2018)
Table 9. Іnоvіо Рhаrmасеutісаlѕ SWOT Analysis
Table 10. Іnоvіо Рhаrmасеutісаlѕ Coronavirus Vaccine Product and Solutions
Table 11. Іnоvіо Рhаrmасеutісаlѕ Coronavirus Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. GGеnеСurе Corporate Information, Location and Competitors
Table 13. GGеnеСurе Coronavirus Vaccine Major Business
Table 14. GGеnеСurе Coronavirus Vaccine Total Revenue (USD Million) (2018-2019)
Table 15. GGеnеСurе SWOT Analysis
Table 16. GGеnеСurе Coronavirus Vaccine Product and Solutions
Table 17. GGеnеСurе Coronavirus Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Рrоtеіn Роtеntіаl Corporate Information, Location and Competitors
Table 19. Рrоtеіn Роtеntіаl Coronavirus Vaccine Major Business
Table 20. Рrоtеіn Роtеntіаl Coronavirus Vaccine Total Revenue (USD Million) (2017-2018)
Table 21. Рrоtеіn Роtеntіаl SWOT Analysis
Table 22. Рrоtеіn Роtеntіаl Coronavirus Vaccine Product and Solutions
Table 23. Рrоtеіn Роtеntіаl Coronavirus Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Моdеrnа Corporate Information, Location and Competitors
Table 25. Моdеrnа Coronavirus Vaccine Major Business
Table 26. Моdеrnа Coronavirus Vaccine Total Revenue (USD Million) (2017-2018)
Table 27. Моdеrnа SWOT Analysis
Table 28. Моdеrnа Coronavirus Vaccine Product and Solutions
Table 29. Моdеrnа Coronavirus Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. NаnоVіrісіdеѕ Corporate Information, Location and Competitors
Table 31. NаnоVіrісіdеѕ Coronavirus Vaccine Major Business
Table 32. NаnоVіrісіdеѕ Coronavirus Vaccine Total Revenue (USD Million) (2017-2018)
Table 33. NаnоVіrісіdеѕ SWOT Analysis
Table 34. NаnоVіrісіdеѕ Coronavirus Vaccine Product and Solutions
Table 35. NаnоVіrісіdеѕ Coronavirus Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Nоvаvах Corporate Information, Location and Competitors
Table 37. Nоvаvах Coronavirus Vaccine Major Business
Table 38. Nоvаvах Coronavirus Vaccine Total Revenue (USD Million) (2017-2018)
Table 39. Nоvаvах SWOT Analysis
Table 40. Nоvаvах Coronavirus Vaccine Product and Solutions
Table 41. Nоvаvах Coronavirus Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Ѕуnаіrgеn РLС Corporate Information, Location and Competitors
Table 43. Ѕуnаіrgеn РLС Coronavirus Vaccine Major Business
Table 44. Ѕуnаіrgеn РLС Coronavirus Vaccine Total Revenue (USD Million) (2017-2018)
Table 45. Ѕуnаіrgеn РLС SWOT Analysis
Table 46. Ѕуnаіrgеn РLС Coronavirus Vaccine Product and Solutions
Table 47. Ѕуnаіrgеn РLС Coronavirus Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. АlрhаVах Corporate Information, Location and Competitors
Table 49. АlрhаVах Coronavirus Vaccine Major Business
Table 50. АlрhаVах Coronavirus Vaccine Total Revenue (USD Million) (2017-2018)
Table 51. АlрhаVах SWOT Analysis
Table 52. АlрhаVах Coronavirus Vaccine Product and Solutions
Table 53. АlрhаVах Coronavirus Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Global Coronavirus Vaccine Revenue (Million USD) by Players (2015-2020)
Table 55. Global Coronavirus Vaccine Revenue Share by Players (2015-2020)
Table 56. Global Coronavirus Vaccine Revenue (Million USD) by Regions (2015-2020)
Table 57. Global Coronavirus Vaccine Revenue Market Share by Regions (2015-2020)
Table 58. North America Coronavirus Vaccine Revenue by Countries (2015-2020)
Table 59. North America Coronavirus Vaccine Revenue Market Share by Countries (2015-2020)
Table 60. Europe Coronavirus Vaccine Revenue (Million USD) by Countries (2015-2020)
Table 61. Asia-Pacific Coronavirus Vaccine Revenue (Million USD) by Countries (2015-2020)
Table 62. South America Coronavirus Vaccine Revenue by Countries (2015-2020)
Table 63. South America Coronavirus Vaccine Revenue Market Share by Countries (2015-2020)
Table 64. Middle East and Africa Coronavirus Vaccine Revenue (Million USD) by Countries (2015-2020)
Table 65. Middle East and Africa Coronavirus Vaccine Revenue Market Share by Countries (2015-2020)
Table 66. Global Coronavirus Vaccine Revenue (Million USD) by Type (2015-2020)
Table 67. Global Coronavirus Vaccine Revenue Share by Type (2015-2020)
Table 68. Global Coronavirus Vaccine Revenue Forecast by Type (2021-2025)
Table 69. Global Coronavirus Vaccine Revenue by Application (2015-2020)
Table 70. Global Coronavirus Vaccine Revenue Share by Application (2015-2020)
Table 71. Global Coronavirus Vaccine Revenue Forecast by Application (2021-2025)
Table 72. Global Coronavirus Vaccine Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Coronavirus Vaccine Picture
Figure 2. Global Coronavirus Vaccine Revenue Market Share by Type in 2019
Figure 3. Coronavirus Inactivated Vaccine Picture
Figure 4. Live Attenuated Coronavirus Vaccine Picture
Figure 5. Coronavirus Vaccine Based On S Protein Picture
Figure 6. Coronavirus Vaccine Revenue Market Share by Application in 2019
Figure 7. Hospital Picture
Figure 8. Clinic Picture
Figure 9. Research Institute Picture
Figure 10. Other Picture
Figure 11. Global Coronavirus Vaccine Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Coronavirus Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Coronavirus Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Coronavirus Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Coronavirus Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Coronavirus Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Coronavirus Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Coronavirus Vaccine Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Coronavirus Vaccine Revenue Market Share in 2019
Figure 20. Global Top 10 Players Coronavirus Vaccine Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Coronavirus Vaccine Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Coronavirus Vaccine Revenue Market Share by Regions (2015-2020)
Figure 24. Global Coronavirus Vaccine Revenue Market Share by Regions in 2018
Figure 25. North America Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
Figure 26. Europe Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
Figure 28. South America Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
Figure 30. North America Coronavirus Vaccine Revenue Market Share by Countries (2015-2020)
Figure 31. North America Coronavirus Vaccine Revenue Market Share by Countries in 2019
Figure 32. USA Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
Figure 33. Canada Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
Figure 35. Europe Coronavirus Vaccine Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Coronavirus Vaccine Revenue Market Share by Countries in 2019
Figure 37. Germany Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
Figure 38. UK Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
Figure 39. France Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
Figure 40. Russia Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
Figure 41. Italy Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Coronavirus Vaccine Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Coronavirus Vaccine Revenue Market Share by Countries in 2019
Figure 44. China Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
Figure 45. Japan Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
Figure 46. Korea Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
Figure 47. India Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
Figure 49. South America Coronavirus Vaccine Revenue Market Share by Countries (2015-2020)
Figure 50. South America Coronavirus Vaccine Revenue Market Share by Countries in 2019
Figure 51. Brazil Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Coronavirus Vaccine Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Coronavirus Vaccine Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
Figure 56. UAE Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Coronavirus Vaccine Revenue and Growth Rate (2015-2020)
Figure 59. Global Coronavirus Vaccine Revenue Share by Type (2015-2020)
Figure 60. Global Coronavirus Vaccine Revenue Share by Type in 2019
Figure 61. Global Coronavirus Vaccine Market Share Forecast by Type (2021-2025)
Figure 62. Global Coronavirus Inactivated Vaccine Revenue Growth Rate (2015-2020)
Figure 63. Global Live Attenuated Coronavirus Vaccine Revenue Growth Rate (2015-2020)
Figure 64. Global Coronavirus Vaccine Based On S Protein Revenue Growth Rate (2015-2020)
Figure 65. Global Coronavirus Vaccine Revenue Share by Application (2015-2020)
Figure 66. Global Coronavirus Vaccine Revenue Share by Application in 2019
Figure 67. Global Coronavirus Vaccine Market Share Forecast by Application (2021-2025)
Figure 68. Global Hospital Revenue Growth Rate (2015-2020)
Figure 69. Global Clinic Revenue Growth Rate (2015-2020)
Figure 70. Global Research Institute Revenue Growth Rate (2015-2020)
Figure 71. Global Other Revenue Growth Rate (2015-2020)
Figure 72. Global Coronavirus Vaccine Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Coronavirus Vaccine Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Coronavirus Vaccine Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Coronavirus Vaccine Revenue Market Forecast (2021-2025)
Figure 76. Europe Coronavirus Vaccine Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Coronavirus Vaccine Revenue Market Forecast (2021-2025)
Figure 78. South America Coronavirus Vaccine Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Coronavirus Vaccine Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
新型コロナウイルス（COVID-19）治療薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Novel Coronavirus (COVID-19) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain …- 新型コロナウイルス感染症診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Coronavirus Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Coronavirus Diagnosti…
- 新規コロナウイルス（COVID-19）・疫病に対するAIの世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The AI to Novel Coronavirus (COVID-19) and Epidemic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players,…
- 新型コロナウイルス感染症用リアルタイム検出キットの世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The global Coronavirus Real-Time Detection Kits market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Coronavi…
- 水痘弱毒生ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Varicella Attenuated Live Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain o…